Elevation of systolic blood pressure in an animal model of olanzapine induced weight gain.
In the present study, we examined the effect of olanzapine on weight gain, systolic blood pressure and metabolic changes in rats. Female Sprague Dawley rats were treated with either vehicle or olanzapine (1 and 2 mg/kg i.p, twice daily) for 20 days. Body weight, food and water intake, systolic blood pressure, plasma glucose, insulin and lipid were measured. Olanzapine (1 and 2 mg/kg) significantly increased the body weight and systolic blood pressure. Whereas, food intake and plasma insulin and insulin resistance index, were elevated only at 1 mg/kg. In conclusion, olanzapine induced weight gain in rats is associated with elevation of systolic blood pressure.
Patil
Basanagouda M
BM
Department of Pharmacology and Toxicology, KLES's College of Pharmacy, J N Medical College Campus, Nehru Nagar, Belgaum-590010, Karnataka, India. bmpatil59@hotamil.com
Kulkarni
Nagaraj M
NM
Unger
Banappa S
BS
D000818:Animals; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000494:pharmacology*; D001569:Benzodiazepines / Q000009:adverse effects / Q000494:pharmacology; D001786:Blood Glucose / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D004326:Drinking / Q000187:drug effects; D004435:Eating / Q000187:drug effects; D005260:Female; D007328:Insulin / Q000097:blood; D007333:Insulin Resistance; D008055:Lipids / Q000097:blood; D023421:Models, Animal; D000077152:Olanzapine; D051381:Rats; D017207:Rats, Sprague-Dawley; D013599:Systole; D013997:Time Factors; D015430:Weight Gain / Q000187:drug effects*
D014150:Antipsychotic Agents; D001786:Blood Glucose; D007328:Insulin; D008055:Lipids; D001569:Benzodiazepines; D000077152:Olanzapine